pxl770
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 21, 2017 (NCT03395470)
Timeline
Indications
Mechanism of action
PRKAB1 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05146284 | Phase 2 | Mar 31, 2022 | Poxel SA |
| NCT05441904 | Phase 1 | Mar 8, 2021 | Poxel SA |
| NCT03950882 | Phase 1 | May 27, 2019 | Poxel SA |
| NCT03763877 | Phase 2 | Mar 29, 2019 | Poxel SA |
| NCT03886103 | Phase 1 | Feb 6, 2019 | Poxel SA |
| NCT03395470 | Phase 1 | Aug 21, 2017 | Poxel SA |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Poxel SA | For profit | 6 | 6 | 2 | 2017 |
1 organizations
Page 1 / 1